These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 26807108)

  • 1. Chemotactic signaling and beyond: link between interleukin-16 and axonal degeneration in multiple sclerosis.
    Skundric DS
    Neural Regen Res; 2015 Nov; 10(11):1761-3. PubMed ID: 26807108
    [No Abstract]   [Full Text] [Related]  

  • 2. Relationship of acute axonal damage, Wallerian degeneration, and clinical disability in multiple sclerosis.
    Singh S; Dallenga T; Winkler A; Roemer S; Maruschak B; Siebert H; Brück W; Stadelmann C
    J Neuroinflammation; 2017 Mar; 14(1):57. PubMed ID: 28302146
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Novel therapeutic targets for axonal degeneration in multiple sclerosis.
    Petratos S; Azari MF; Ozturk E; Papadopoulos R; Bernard CC
    J Neuropathol Exp Neurol; 2010 Apr; 69(4):323-34. PubMed ID: 20448478
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Axonal pathology in multiple sclerosis: relationship to neurologic disability.
    Trapp BD; Ransohoff R; Rudick R
    Curr Opin Neurol; 1999 Jun; 12(3):295-302. PubMed ID: 10499174
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inflammatory responses in Multiple Sclerosis normal-appearing white matter and in non-immune mediated neurological conditions with wallerian axonal degeneration: A comparative study.
    Vercellino M; Trebini C; Capello E; Mancardi GL; Giordana MT; Cavalla P
    J Neuroimmunol; 2017 Nov; 312():49-58. PubMed ID: 28919237
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Contrasting roles for axonal degeneration in an autoimmune versus viral model of multiple sclerosis: When can axonal injury be beneficial?
    Tsunoda I; Tanaka T; Terry EJ; Fujinami RS
    Am J Pathol; 2007 Jan; 170(1):214-26. PubMed ID: 17200195
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Axonal degeneration in the peripheral nervous system: implications for the pathogenesis of amyotrophic lateral sclerosis.
    Fischer-Hayes LR; Brotherton T; Glass JD
    Exp Neurol; 2013 Aug; 246():6-13. PubMed ID: 23664960
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Axonal degeneration in the pathogenesis of multiple sclerosis.
    Silber E; Sharief MK
    J Neurol Sci; 1999 Nov; 170(1):11-8. PubMed ID: 10540030
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Axonal degeneration in the pathogenesis of multiple sclerosis].
    Mirowska D; Członkowska A
    Neurol Neurochir Pol; 2002; 36(4):777-89. PubMed ID: 12418141
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of nitric oxide to axonal degeneration in multiple sclerosis via downregulating monocarboxylate transporter 1 in oligodendrocytes.
    Tang X; Lan M; Zhang M; Yao Z
    Nitric Oxide; 2017 Jul; 67():75-80. PubMed ID: 28392448
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The slow Wallerian degeneration gene, WldS, inhibits axonal spheroid pathology in gracile axonal dystrophy mice.
    Mi W; Beirowski B; Gillingwater TH; Adalbert R; Wagner D; Grumme D; Osaka H; Conforti L; Arnhold S; Addicks K; Wada K; Ribchester RR; Coleman MP
    Brain; 2005 Feb; 128(Pt 2):405-16. PubMed ID: 15644421
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Axonal degeneration in multiple sclerosis: defining therapeutic targets by identifying the causes of pathology.
    Lee JY; Biemond M; Petratos S
    Neurodegener Dis Manag; 2015 Dec; 5(6):527-48. PubMed ID: 26619755
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The central role of mitochondria in axonal degeneration in multiple sclerosis.
    Campbell GR; Worrall JT; Mahad DJ
    Mult Scler; 2014 Dec; 20(14):1806-13. PubMed ID: 25122475
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Distribution of a calcium channel subunit in dystrophic axons in multiple sclerosis and experimental autoimmune encephalomyelitis.
    Kornek B; Storch MK; Bauer J; Djamshidian A; Weissert R; Wallstroem E; Stefferl A; Zimprich F; Olsson T; Linington C; Schmidbauer M; Lassmann H
    Brain; 2001 Jun; 124(Pt 6):1114-24. PubMed ID: 11353727
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Morphometric and biochemical studies of peripheral nerves in amyotrophic lateral sclerosis.
    Bradley WG; Good P; Rasool CG; Adelman LS
    Ann Neurol; 1983 Sep; 14(3):267-77. PubMed ID: 6195954
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Patients lacking the major CNS myelin protein, proteolipid protein 1, develop length-dependent axonal degeneration in the absence of demyelination and inflammation.
    Garbern JY; Yool DA; Moore GJ; Wilds IB; Faulk MW; Klugmann M; Nave KA; Sistermans EA; van der Knaap MS; Bird TD; Shy ME; Kamholz JA; Griffiths IR
    Brain; 2002 Mar; 125(Pt 3):551-61. PubMed ID: 11872612
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Axonal damage in multiple sclerosis].
    Bartosik-Psujek H; Stelmasiak Z
    Neurol Neurochir Pol; 2002; 36(3):505-12. PubMed ID: 12185807
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The enigma of multiple sclerosis: inflammation and neurodegeneration cause heterogeneous dysfunction and damage.
    Owens T
    Curr Opin Neurol; 2003 Jun; 16(3):259-65. PubMed ID: 12858060
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A dam for retrograde axonal degeneration in multiple sclerosis?
    Balk LJ; Twisk JW; Steenwijk MD; Daams M; Tewarie P; Killestein J; Uitdehaag BM; Polman CH; Petzold A
    J Neurol Neurosurg Psychiatry; 2014 Jul; 85(7):782-9. PubMed ID: 24474822
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Imaging neuronal and axonal degeneration in multiple sclerosis.
    De Stefano N; Guidi L; Stromillo ML; Bartolozzi ML; Federico A
    Neurol Sci; 2003 Dec; 24 Suppl 5():S283-6. PubMed ID: 14652790
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.